Deuterium Capital Management »

Altimmune shares owned by Deuterium Capital Management

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Deuterium Capital Management from 13F filings

Historical chart of Deuterium Capital Management investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Deuterium Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Deuterium Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $113k 10k 11.25

More positions owned by Deuterium Capital Management

Intuitive Surgical Com New (ISRG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Enovix Corp (ENVX)
Capri Holdings SHS (CPRI)
Imperial Pete Com New Call Option (IMPP)
Palantir Technologies Cl A (PLTR)
NVIDIA Corporation (NVDA)
Mirati Therapeutics
Sprott Fds Tr Uranium Miners E (URNM)
Global X Fds Global X Uranium (URA)
Neogames S A SHS (NGMS)
Uipath Cl A (PATH)
Invesco Exch Traded Fd Tr Ii S&p Smallcap Ene (PSCE)
Spdr Ser Tr S&p Homebuild (XHB)

View all positions for Deuterium Capital Management

Top funds holding Altimmune

Vanguard Group
Tang Capital Management
Point72 Asset Management
Jane Street
Citadel Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Fred Alger Management
Kennedy Capital Management
Beirne Wealth Consulting Services
Wolverine Trading
D. E. Shaw & Co
Gerber
Dimensional Fund Advisors
GSA Capital Partners

View all funds holding Altimmune